Schonfeld Strategic Advisors LLC - CATABASIS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 55 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$102,000
+18.6%
47,600
+240.0%
0.00%
-50.0%
Q3 2020$86,000–14,000–0.00%–
 Download
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q3 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders